|
1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng L, Jiao W, Song H, Qu H, Li D, Mei
H, Chen Y, Yang F, Li H, Huang K, et al: miRNA-558 promotes gastric
cancer progression through attenuating Smad4-mediated repression of
heparanase expression. Cell Death Dis. 7:e23822016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma
Y, Chen Y, Pan F, Wang K, Ni J, et al: Circulating miR-16-5p and
miR-19b-3p as two novel potential biomarkers to indicate
progression of gastric cancer. Theranostics. 5:733–745. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsai MM, Wang CS, Tsai CY, Huang HW, Chi
HC, Lin YH, Lu PH and Lin KH: Potential diagnostic, prognostic and
therapeutic targets of microRNAs in human gastric cancer. Int J Mol
Sci. 17:9452016. View Article : Google Scholar
|
|
5
|
An Y, Zhang Z, Shang Y, Jiang X, Dong J,
Yu P, Nie Y and Zhao Q: miR-23b-3p regulates the chemoresistance of
gastric cancer cells by targeting ATG12 and HMGB2. Cell Death Dis.
6:e17662015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hurst DR, Edmonds MD and Welch DR:
Metastamir: The field of metastasis-regulatory microRNA is
spreading. Cancer Res. 69:7495–7498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahn SM, Cha JY, Kim J, Kim D, Trang HT,
Kim YM, Cho YH, Park D and Hong S: Smad3 regulates E-cadherin via
miRNA-200 pathway. Oncogene. 31:3051–3059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zuo QF, Cao LY, Yu T, Gong L, Wang LN,
Zhao YL, Xiao B and Zou QM: MicroRNA-22 inhibits tumor growth and
metastasis in gastric cancer by directly targeting MMP14 and Snail.
Cell Death Dis. 6:e20002015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhan XH, Xu QY, Tian R, Yan H, Zhang M, Wu
J, Wang W and He J: MicroRNA16 regulates glioma cell proliferation,
apoptosis and invasion by targeting Wip1-ATM-p53 feedback loop.
Oncotarget. 8:54788–54798. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang W, Chen J, Dai J, Zhang B, Wang F and
Sun Y: MicroRNA-16-1 inhibits tumor cell proliferation and induces
apoptosis in A549 non-small cell lung carcinoma cells. Oncol Res.
24:345–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diamantopoulos MA, Kontos CK, Kerimis D,
Papadopoulos IN and Scorilas A: Upregulated miR-16 expression is an
independent indicator of relapse and poor overall survival of
colorectal adenocarcinoma patients. Clin Chem Lab Med. 55:737–747.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tatetsu H, Kong NR, Chong G, Amabile G,
Tenen DG and Chai L: SALL4, the missing link between stem cells,
development and cancer. Gene. 584:111–119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Warren M, Wang W, Spiden S, Chen-Murchie
D, Tannahill D, Steel KP and Bradley A: A Sall4 mutant mouse model
useful for studying the role of Sall4 in early embryonic
development and organogenesis. Genesis. 45:51–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Rao S, Chu J, Shen X, Levasseur
DN, Theunissen TW and Orkin SH: A protein interaction network for
pluripotency of embryonic stem cells. Nature. 444:364–368. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY,
Soh BS, Lou Y, Yang J, Ma Y, Chai L, et al: Sall4 modulates
embryonic stem cell pluripotency and early embryonic development by
the transcriptional regulation of Pou5f1. Nat Cell Biol.
8:1114–1123. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Q, Chen X, Zhang J, Loh YH, Low TY,
Zhang W, Zhang W, Sze SK, Lim B and Ng HH: Sall4 interacts with
Nanog and co-occupies Nanog genomic sites in embryonic stem cells.
J Biol Chem. 281:24090–24094. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oikawa T, Kamiya A, Zeniya M, Chikada H,
Hyuck AD, Yamazaki Y, Wauthier E, Tajiri H, Miller LD, Wang XW, et
al: Sal-like protein 4 (SALL4), a stem cell biomarker in liver
cancers. Hepatology. 57:1469–1483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kobayashi D, Kuribayashi K, Tanaka M and
Watanabe N: Overexpression of SALL4 in lung cancer and its
importance in cell proliferation. Oncol Rep. 26:965–970.
2011.PubMed/NCBI
|
|
19
|
Kobayashi D, Kuribayshi K, Tanaka M and
Watanabe N: SALL4 is essential for cancer cell proliferation and is
overexpressed at early clinical stages in breast cancer. Int J
Oncol. 38:933–939. 2011.PubMed/NCBI
|
|
20
|
Khales Ardalan S, Abbaszadegan MR,
Abdollahi A, Raeisossadati R, Tousi MF and Forghanifard MM: SALL4
as a new biomarker for early colorectal cancers. J Cancer Res Clin
Oncol. 141:229–235. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Itou J, Matsumoto Y, Yoshikawa K and Toi
M: Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell
dispersion in basal-like breast cancer. FEBS Lett. 587:3115–3121.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li A, Jiao Y, Yong KJ, Wang F, Gao C, Yan
B, Srivastava S, Lim GS, Tang P, Yang H, et al: SALL4 is a new
target in endometrial cancer. Oncogene. 34:63–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang X, Yuan X, Zhu W, Qian H and Xu W:
SALL4: An emerging cancer biomarker and target. Cancer Lett.
357:55–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang
M, Zhang X, Yang T, Cai J, Yan Y, et al: SALL4, a novel marker for
human gastric carcinogenesis and metastasis. Oncogene.
33:5491–5500. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yuan X, Zhang X, Zhang W, Liang W, Zhang
P, Shi H, Zhang B, Shao M, Yan Y, Qian H, et al: SALL4 promotes
gastric cancer progression through activating CD44 expression.
Oncogenesis. 5:e2682016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ishiguro H, Kimura M and Takeyama H: Role
of microRNAs in gastric cancer. World J Gastroenterol.
20:5694–5699. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amaral FC, Torres N, Saggioro F, Neder L,
Machado HR, Silva WA Jr, Moreira AC and Castro M: MicroRNAs
differentially expressed in ACTH-secreting pituitary tumors. J Clin
Endocrinol Metab. 94:320–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Venturutti L, Russo Cordo RI, Rivas MA,
Mercogliano MF, Izzo F, Oakley RH, Pereyra MG, De Martino M,
Proietti CJ, Yankilevich P, et al: MiR-16 mediates trastuzumab and
lapatinib response in ErbB-2-positive breast and gastric cancer via
its novel targets CCNJ and FUBP1. Oncogene. 35:6189–6202. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kang W, Tong JH, Lung RW, Dong Y, Zhao J,
Liang Q, Zhang L, Pan Y, Yang W, Pang JC, et al: Targeting of YAP1
by microRNA-15a and microRNA-16-1 exerts tumor suppressor function
in gastric adenocarcinoma. Mol Cancer. 14:522015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang T, Hou J, Li Z, Zheng Z, Wei J, Song
D, Hu T, Wu Q, Yang JY and Cai JC: miR-15a-3p and miR-16-1-3p
negatively regulate Twist1 to repress gastric cancer cell invasion
and metastasis. Int J Biol Sci. 13:122–134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gautam AK, Wang C, Zeng J, Wang J, Lu J,
Wei J, Huang G and Mo B, Luo M and Mo B: Expression and clinical
significance of SALL4 and LGR5 in patients with lung cancer. Oncol
Lett. 10:3629–3634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanaka Y, Aishima S, Kohashi K, Okumura Y,
Wang H, Hida T, Kotoh K, Shirabe K, Maehara Y, Takayanagi R, et al:
Spalt-like transcription factor 4 immunopositivity is associated
with epithelial cell adhesion molecule expression in combined
hepatocellular carcinoma and cholangiocarcinoma. Histopathology.
68:693–701. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dirican E and Akkiprik M: Functional and
clinical significance of SALL4 in breast cancer. Tumour Biol.
37:11701–11709. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu J, Wang L, Yang A, Jiang P and Wang M:
Up-regulation of SALL4 associated with poor prognosis in gastric
cancer. Hepatogastroenterology. 61:1459–1464. 2014.PubMed/NCBI
|
|
37
|
Tian Q, Xiao Y, Wu Y, Liu Y, Song Z, Gao
W, Zhang J, Yang J, Zhang Y, Guo T, et al: MicroRNA-33b suppresses
the proliferation and metastasis of hepatocellular carcinoma cells
through the inhibition of Sal-like protein 4 expression. Int J Mol
Med. 38:1587–1595. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou Y, Liu Y, Hu C and Jiang Y:
MicroRNA-16 inhibits the proliferation, migration and invasion of
glioma cells by targeting Sal-like protein 4. Int J Mol Med.
38:1768–1776. 2016. View Article : Google Scholar : PubMed/NCBI
|
